Fiera Capital (Canada)
CLLS

Fiera Capital (Canada)’s Cellectis CLLS Stock Holding History

Fiera Capital (Canada)’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,952
Closed -$203K – 661
2016
Q4 		$203K Hold
11,952
– – ﹤0.01% 726
2016
Q3 		$288K Sell
11,952
-5,047
-30% -$132K ﹤0.01% 656
2016
Q2 		$452K Buy
+16,999
New +$498K ﹤0.01% 654

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Fiera Capital (Canada)'s CLLS Position: Q1 2017 in Review

Fiera Capital (Canada) sold out of Cellectis (CLLS) in Q1 2017, closing a stake of 11,952 shares — an estimated $203K sold.

Fiera Capital (Canada) first reported a position in CLLS in Q2 2016 and held it in 3 quarters. The position peaked at $452K in Q2 2016. 40 funds tracked by Wall St. Rank hold CLLS as of Q1 2017.

  • Fiera Capital (Canada) reported no remaining Cellectis position as of Q1 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 11,952 Cellectis shares in Q1 2017, an estimated $203K.
  • Fiera Capital (Canada) first reported a position in Cellectis in Q2 2016 and held it in 3 quarters.
  • Fiera Capital (Canada)'s Cellectis position peaked at $452K in Q2 2016.
  • 40 funds tracked by Wall St. Rank held Cellectis as of Q1 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2017, filed 15 May 2017.